Thursday, July 23, 2009

New Study Shows Agent Can Improve Muscle Strength, Size, in Mouse ALS Model

click on the link above for information about a phase I trial at Johns Hopkins' ALS Packard Center in Baltimore of a new agent which is believed to slow down muscle-wasting in ALS patients.

1 comment:

Anonymous said...

Those are SOD1 mice, and most of us human pALS (90%+) have sporadic ALS.
(Mary Jo from Canada)